Clearance of Somatic Mutations and the Effect on Risk of Relapse in AML
Clearance of somatic mutation at complete remission is associated with significantly better survival in patients with acute myeloid leukemia.
AML Immune Profile Linked With Relapse-Free Survival
Immune-enriched acute myeloid leukemia may be responsive to immunotherapy that is tailored to the bone marrow tumor microenvironment.
Relapse Common for Patients With Complex Karyotype AML After Transplantation
A recent study investigated the most common causes of treatment failure for patients with complex karyotype acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation.
AML Treatment at NCI Centers Associated With Reduced Early Mortality
Initial treatment of adult patients with acute myeloid leukemia at National Cancer Institute-designated cancer centers has been linked to a 53% reduction in the likelihood of early mortality.
